Evidence map›Paper›PMID 27196129›Full record

ArticleCell adhesion & migration2017

Non-pungent long chain capsaicin-analogs arvanil and olvanil display better anti-invasive activity than capsaicin in human small cell lung cancers.

John D Hurley, Austin T Akers, Jamie R Friedman, Nicholas A Nolan, Kathleen C Brown, Piyali Dasgupta

Open access · goldAbstract read
In one paragraph

Article in Cell adhesion & migration, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Nonpungent N-AVAM Capsaicin Analogues and Cancer Therapy.Journal of medicinal chemistry · 2021
    Article
  10. Biological Properties, Bioactive Constituents, and Pharmacokinetics of SomeInternational journal of molecular sciences · 2020
    Review
  11. Capsaicinoids: Multiple effects on angiogenesis, invasion and metastasis in human cancers.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2019
    Review
  12. Article
  13. Anticancer Activity of Natural and Synthetic Capsaicin Analogs.The Journal of pharmacology and experimental therapeutics · 2018
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

John D Hurleya Department of Pharmacology, Physiology, and Toxicology , Joan C. Edwards School of Medicine, Marshall University , Huntington , WV , USA.
Austin T Akersa Department of Pharmacology, Physiology, and Toxicology , Joan C. Edwards School of Medicine, Marshall University , Huntington , WV , USA.
Jamie R Friedmana Department of Pharmacology, Physiology, and Toxicology , Joan C. Edwards School of Medicine, Marshall University , Huntington , WV , USA.
Nicholas A Nolana Department of Pharmacology, Physiology, and Toxicology , Joan C. Edwards School of Medicine, Marshall University , Huntington , WV , USA.
Kathleen C Browna Department of Pharmacology, Physiology, and Toxicology , Joan C. Edwards School of Medicine, Marshall University , Huntington , WV , USA.
Piyali Dasguptaa Department of Pharmacology, Physiology, and Toxicology , Joan C. Edwards School of Medicine, Marshall University , Huntington , WV , USA.
Marshall University · US

Funding

Capsaicin and Small cell Lung Cancer TherapyR15CA161491 · NCI · MARSHALL UNIVERSITY · PI DASGUPTA, PIYALI · 2012 to 2021
$1.3M
NCI NIH HHS R15 CA161491
6 · The paper itself

Abstract

The nutritional compound capsaicin inhibits the invasion of many types of human cancers. The clinical development of capsaicin as an anti-cancer drug is limited due to its unfavorable side effects like burning sensation, stomach cramps, gut pain and nausea. This study compared the anti-invasive activity of capsaicin to non-pungent long chain capsaicin analogs, namely arvanil and olvanil, in human small cell lung cancer cells. Boyden chamber invasion assays revealed that arvanil and olvanil displayed improved anti-invasive activity relative to capsaicin in human SCLC cells. The results of the Boyden chamber assay were confirmed by the spherical invasion assay, and similar results were obtained. The anti-invasive activity of arvanil, olvanil and capsaicin were independent of TRPV and CB1 receptors. Furthermore, the anti-invasive activity of arvanil, olvanil and capsaicin was mediated by the AMPK pathway. Depletion of AMPK levels by siRNA methodology abrogated the anti-invasive activity of arvanil, olvanil and capsaicin. The non-pungent capsaicin analogs arvanil and olvanil display improved anti-invasive activity relative to capsaicin in human SCLC cells. These agents may represent the second generation of capsaicin-like compounds which are more potent than the parent molecule and have a better side effect profile.

Indexed as

Adenylate KinaseAnimalsCapsaicinCell Line, TumorHumansLung NeoplasmsNeoplasm InvasivenessReceptor, Cannabinoid, CB1Signal TransductionSmall Cell Lung CarcinomaTime FactorsTRPV Cation ChannelsAdenylate KinasearvanilCapsaicinolvanilReceptor, Cannabinoid, CB1TRPV Cation ChannelsAMPKarvanilcapsaicininvasionolvanilSCLC

Identifiers

PMID27196129
PMCPMC5308228
OpenAlexW2405704180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.